Urgent drainage and source control

01Purpose and principlesWhat the treatment does and how it fits into care.

Source control means physically eliminating the focus that sustains infection: draining pus, opening infected compartments, removing necrotic soft tissue or bone, extracting foreign material and restoring drainage. Diabetic neuropathy can mask pain, while PAD blunts inflammation and limits healing. A small skin opening may therefore conceal extensive plantar-space, tendon-sheath or bone infection. Antimicrobials support source control but cannot substitute for it.

The initial decision is urgency, not the exact organism. Severe infection or NICE limb-threatening features trigger immediate acute referral. Examine haemodynamics, metabolic status, perfusion and the anatomical extent of infection together. Plain radiography can reveal gas and foreign bodies; MRI maps uncertain deep spread in a stable patient. An obvious abscess, compartment syndrome or necrotising process proceeds to surgery without waiting for advanced imaging. PAD must be addressed concurrently because debridement without adequate inflow may enlarge non-healing tissue loss.

Key points

Sepsis, necrotising change, deep abscess, gangrene or infection with severe ischaemia requires immediate acute referral and urgent surgical assessment; do not wait for MRI.
Antibiotics penetrate viable tissue but cannot drain pus or remove necrotic material; obtain source control while resuscitation and antimicrobial therapy proceed in parallel.
When PAD accompanies infection or gangrene, involve surgical and vascular specialists urgently to sequence drainage, debridement and revascularisation without sacrificing viable tissue.
Take blood cultures for systemic illness and aseptic deep tissue and bone samples at drainage; superficial swabs mainly reflect colonisers.
IWGDF advises considering early surgery within 24–48 hours for selected moderate or severe infections, but unstable or necrotising disease may need still faster intervention.
Explore connected compartments and tendon sheaths, remove non-viable tissue, drain all collections and preserve viable load-bearing structures whenever possible.
Reassess after the first operation because demarcation, perfusion and residual infection evolve; planned return to theatre may be safer than either inadequate or destructive one-stage surgery.

02Indications, selection and cautionsWho may benefit, who needs urgent treatment and important alternatives.

Deep collection

Fluctuance, focal swelling, purulent tracking, loss of normal tissue planes or discharge from a distant point suggests an abscess. Neuropathy may make palpation surprisingly painless, so compare both feet and inspect every surface.

Necrotising pattern

Rapid progression, severe or unexpected pain, skin anaesthesia, bullae, crepitus, grey tissue, systemic toxicity and deep gas demand immediate senior surgical review. A reassuring laboratory score cannot rule out the diagnosis.

Compartment spread

Infection can follow tendons and fascial spaces from a small ulcer. Examine toes, web spaces, plantar arch, heel and ankle; restricted movement, tense swelling or proximal tenderness can reveal the hidden route.

Non-viable tissue

Black or grey tissue, absent bleeding, loss of contractility and foul liquefaction identify material that may sustain infection. Dry ischaemic gangrene without infection differs and requires vascular planning before indiscriminate debridement.

Systemic severityRed flag

Use observations, mental state, urine output, glucose, ketones, lactate and organ function to identify severe infection and sepsis. Formal IWGDF severe grading requires at least two SIRS findings.

Red flags requiring action

Hypotension, confusion, fever or hypothermia, tachycardia, tachypnoea, oliguria or metabolic deterioration indicates systemic infection and possible organ dysfunction.
Crepitus, bullae, dusky anaesthesia, disproportionate pain, rapid spread or gas in deep tissues raises concern for necrotising soft-tissue infection.
Fluctuance, purulent tracking, a tense swollen compartment, exposed joint or tendon, or deep focal tenderness suggests a collection requiring drainage.
Gangrene, new coolness, absent Doppler signals or sharply worsening necrosis makes vascular assessment and revascularisation planning urgent alongside infection control.

03Assessment before treatmentTests and checks that guide safe selection.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Immediate clinical and perfusion assessmentFirst step
Why
Determine sepsis severity, anatomical source and whether ischaemia changes operative timing and healing potential.
Interpretation and limitations
Instability, necrotising signs, deep collection or gangrene mandates emergency escalation. Record pulses and Doppler signals, but do not delay transfer for pressure testing when the limb or patient is threatened.
02
Plain foot radiographs
Why
Look quickly for deep gas, foreign material, bone destruction and baseline deformity before or around surgery.
Interpretation and limitations
Deep gas increases urgency; cortical destruction supports osteomyelitis. A normal film cannot exclude an early abscess or bone infection and must not overrule the examination.
03
Bloods and blood cultures
Why
Measure systemic impact, metabolic disturbance, renal dosing constraints and bloodstream infection in an unwell patient.
Interpretation and limitations
Obtain cultures before antibiotics when this causes no harmful delay. CRP and white count help trend response but normal values cannot exclude a deep local infection.
04
Cross-sectional imaging
Why
Map an uncertain collection, sinus, joint or bone extent when the patient is stable enough and imaging will alter surgery.
Interpretation and limitations
MRI shows soft tissue and marrow detail; CT may demonstrate gas and anatomy rapidly. Neither should postpone drainage of a clinically evident collection or necrotising process.
05
Operative deep tissue and bone
Why
Identify invasive pathogens and residual osteomyelitis so empirical antibiotics can be narrowed appropriately.
Interpretation and limitations
Send separate aseptic specimens from defined sites, ideally before contamination by superficial flora. Bone culture and histology provide stronger evidence than a surface swab.

04Treatment approachPreparation, options, escalation and aftercare.

01Emergency pathwayDrain the threatened footFirst stepSepsis, necrotising features, deep abscess, compartment infection, extensive gangrene or rapidly deteriorating tissue is present.

1Refer immediately, activate senior surgical and multidisciplinary foot care input, resuscitate using sepsis principles and start intravenous antibiotics after prompt cultures when feasible.
2Obtain urgent vascular assessment when ischaemia or gangrene is present, while preparing for incision, drainage and debridement; do not wait for outpatient tests or MRI.
3Explore involved compartments, drain pus, excise clearly non-viable tissue, send labelled deep specimens and preserve viable tendons, joints and weight-bearing structures where safe.
4Plan early postoperative reassessment and possible repeat debridement, revising antibiotics to cultures and coordinating revascularisation, offloading and wound coverage.

02Preferred branchStable deep infection mappingPreferredDeep extension is suspected but the patient is stable and there is no clinically obvious collection demanding immediate drainage.

1Obtain plain radiographs, inflammatory markers and expert examination; use MRI when it will define bone, joint, tendon or abscess involvement.
2EscalationCollect aseptic deep tissue or bone, then start severity-appropriate treatment and agree a clear threshold for operative escalation.
3Review within 24–48 hours or sooner for deterioration; lack of improvement prompts renewed search for retained pus, necrosis, foreign material and ischaemia.

03After source controlRebuild the healing pathwayInitial drainage or debridement has controlled the immediate septic focus and the remaining tissue must be reassessed.

1Re-examine viability and perfusion, review operative findings and pathology, and narrow antibiotics when microbiology permits.
2DefinitiveChoose offloading and dressings that allow the needed inspection, and restore perfusion before definitive closure when indicated.
3Track wound dimensions, inflammatory features, renal function and functional goals; return to theatre if residual or recurrent source becomes evident.

05Regimens, contraindications and interactionsTreatment details and the circumstances that modify them.

One NICE empirical option while source control and microbiology are pursued in a moderate or severe infection.

Co-amoxiclav

For moderate or severe infection, 500/125 mg orally three times daily or 1.2 g intravenously three times daily; treat at least 7 days and extend only by clinical indication.

Avoid in serious penicillin allergy or previous co-amoxiclav-associated jaundice. If creatinine clearance is >30 mL/min use the stated dose; at 10–30 use 500/125 mg orally twice daily, or after an initial 1.2 g IV dose use 500/100 mg IV twice daily; below 10 use the oral dose once daily, or initial 1.2 g IV then 500/100 mg IV every 24 hours. During haemodialysis, give oral 500/125 mg every 24 hours plus a dose during and after dialysis, or IV initial 1.2 g then 500/100 mg every 24 hours plus 500/100 mg after dialysis. Review IV therapy by 48 hours, monitor hepatic toxicity and narrow by cultures.

Provides additional Gram-negative cover in selected severe or complicated regimens while cultures are pending.

Gentamicin

Give an initial 5–7 mg/kg intravenously once daily when selected; determine later doses from serum concentrations, renal function and the local monitored dosing protocol.

Use measured weight, drug levels and repeated renal assessment; minimise other nephrotoxic or ototoxic drugs. Frailty, pregnancy and kidney impairment require specialist review, and treatment should stop when narrower therapy is adequate.

06Complications, monitoring and follow-upAdverse effects, response and longer-term review.

Repeat observations, perfusion findings, glucose and organ function frequently until systemic and limb trajectories are clearly improving.
Inspect the wound after drainage for residual pockets, advancing necrosis, new tracking and tissue viability; schedule a second look when uncertainty remains.
Review cultures and histology daily when available, narrowing antibiotics and defining duration from residual soft-tissue and bone infection.
Check renal function and drug levels during nephrotoxic therapy and reassess intravenous need by 48 hours for oral switch when possible.
Escalate again for persistent fever, rising inflammatory burden, spreading tissue loss, new gas, worsening ischaemia or failure of the wound to stabilise.

07Special situationsVariants, exceptions and circumstances that change the usual approach.

Small aperture, large cavity

A plantar ulcer may be the mouth of a much wider infected space. Probe gently, examine along tendon paths and use imaging only when it will not delay obvious drainage.

Debridement has an endpoint

Remove dead and infected material until viable tissue and drainage are achieved, while avoiding unnecessary loss of structural tissue. Staged operations can reconcile infection control with preservation.

Perfusion and pus interact

Ischaemia reduces immune delivery and healing, yet uncontrolled sepsis cannot always wait for revascularisation. Joint vascular and surgical planning decides whether drainage, inflow restoration or both proceed first.

Margins answer different questions

Soft-tissue viability, bone culture and bone histology each inform different decisions. Clearly label anatomical sites so a positive result can be linked to retained rather than discarded tissue.

Failure is usually anatomical

When active antibiotics do not produce early improvement, reconsider an undrained collection, necrotic bone, foreign body, pressure or inadequate inflow before simply adding broader agents.

08Common pitfallsFrequent interpretation and management errors.

01
Delaying surgery for MRI when pus, gas or necrotising signs are already clinically evident loses time without resolving the source.
02
Performing extensive community debridement in a cool pulseless foot before vascular assessment can enlarge irreversible tissue loss.
03
Sending only a superficial swab after antibiotics begin weakens pathogen evidence and may drive unnecessarily broad prolonged treatment.
04
Closing an infected cavity before drainage is dependable can trap residual infection and force a larger later operation.
05
Assuming one operation completes source control misses evolving demarcation, residual compartments and the need for planned second-look assessment.

Find your next topic